Similar articles

• Laser photocoagulation of subfoveal choroidal neovascularization secondary to age-related macular degeneration.

  Hawkins WR. Hawkins WR. Arch Ophthalmol. 1995 May;113(5):554. doi: 10.1001/archopht.1995.01100050016007. Arch Ophthalmol. 1995. PMID: 7538291 No abstract available.
• Laser treatment for subfoveal neovascular membranes in ocular histoplasmosis syndrome: results of a pilot randomized clinical trial.

  Fine SL, Wood WJ, Isernhagen RD, Singerman LJ, Bressler NM, Folk JC, Kimura AE, Fish GE, Maguire MG, Alexander J. Fine SL, et al. Arch Ophthalmol. 1993 Jan;111(1):19-20. doi: 10.1001/archopht.1993.01090010021006. Arch Ophthalmol. 1993. PMID: 7678731 Clinical Trial. No abstract available.
• A new standard of care for laser photocoagulation of subfoveal choroidal neovascularization secondary to age-related macular degeneration. Data revisited.

  Yannuzzi LA. Yannuzzi LA. Arch Ophthalmol. 1994 Apr;112(4):462-4. doi: 10.1001/archopht.1994.01090160038019. Arch Ophthalmol. 1994. PMID: 7512331 No abstract available.
• The peril of the pilot study.

  Ferris FL 3rd, Murphy RP. Ferris FL 3rd, et al. Arch Ophthalmol. 1996 Dec;114(12):1506-7. doi: 10.1001/archopht.1996.01100140704011. Arch Ophthalmol. 1996. PMID: 8953984 Review. No abstract available.
• Surgical removal of submacular hemorrhage and subfoveal choroidal neovascular membranes.

  Thomas MA, Williams DF, Grand MG. Thomas MA, et al. Int Ophthalmol Clin. 1992 Spring;32(2):173-88. doi: 10.1097/00004397-199203220-00016. Int Ophthalmol Clin. 1992. PMID: 1374367 Review. No abstract available.